Lantheus Holdings welcomes new board member
James Clemmer is the newest member of the Lantheus Holdings board of directors, the company announced late last week.
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., which specializes in diagnostic imaging agents and products used primarily in the diagnosis of cardiovascular disease.
"I am delighted to be joining the Board of Lantheus Holdings at this exciting time in the company's development," Clemmer said in a statement. "I look forward to working with the Lantheus team as we continue to build on our leadership position bringing innovative diagnostic medical imaging agents to healthcare providers to assist in patient-critical diagnosis of cardiovascular and other diseases."
Clemmer has over 25 years of experience in the medical device industry, most recently serving as president of the medical supplies segment for Covidien Public Limited Company. In that role, he directed the day-to-day operations of global business divisions responsible for a wide range of products.
"We are pleased to welcome Jim to the board of directors and look forward to working with him to maximize value for patients, healthcare providers and shareholders," Jeff Bailey, Lantheus president and CEO, said in the same statement. "With commercial excellence and supply chain reliability as the backbone of the company, we believe that Jim's broad industry experience and deep functional expertise will be a tremendous asset to the company as we continue to execute our corporate strategy."
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.